mRNA-based cancer therapeutics
Due to the fact that mRNA technology allows the production of diverse vaccines and
treatments in a shorter time frame and with reduced expense compared to conventional …
treatments in a shorter time frame and with reduced expense compared to conventional …
Advances in antibody-based therapy in oncology
S Zinn, R Vazquez-Lombardi, C Zimmermann, P Sapra… - Nature Cancer, 2023 - nature.com
Monoclonal antibodies are a growing class of targeted cancer therapeutics, characterized by
exquisite specificity, long serum half-life, high affinity and immune effector functions. In this …
exquisite specificity, long serum half-life, high affinity and immune effector functions. In this …
Emerging principles of cytokine pharmacology and therapeutics
Cytokines are secreted signalling proteins that play essential roles in the initiation,
maintenance and resolution of immune responses. Although the unique ability of cytokines …
maintenance and resolution of immune responses. Although the unique ability of cytokines …
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
A Quijano-Rubio, AM Bhuiyan, H Yang, I Leung… - Nature …, 2023 - nature.com
The therapeutic potential of recombinant cytokines has been limited by the severe side
effects of systemic administration. We describe a strategy to reduce the dose-limiting …
effects of systemic administration. We describe a strategy to reduce the dose-limiting …
Strategies to therapeutically modulate cytokine action
WJ Leonard, JX Lin - Nature Reviews Drug Discovery, 2023 - nature.com
Cytokines are secreted or membrane-presented molecules that mediate broad cellular
functions, including development, differentiation, growth and survival. Accordingly, the …
functions, including development, differentiation, growth and survival. Accordingly, the …
Reprogramming systemic and local immune function to empower immunotherapy against glioblastoma
S Zhou, Y Huang, Y Chen, Y Liu, L Xie, Y You… - Nature …, 2023 - nature.com
The limited benefits of immunotherapy against glioblastoma (GBM) is closely related to the
paucity of T cells in brain tumor bed. Both systemic and local immunosuppression contribute …
paucity of T cells in brain tumor bed. Both systemic and local immunosuppression contribute …
Immunotherapy for metastatic triple negative breast cancer: current paradigm and future approaches
V Geurts, M Kok - Current Treatment Options in Oncology, 2023 - Springer
Opinion statement In approximately 15–20% of the patients diagnosed with breast cancer, it
comprises the triple negative (TN) subtype, which until recently lacked targets for specific …
comprises the triple negative (TN) subtype, which until recently lacked targets for specific …
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies
Effective antitumor immunity in mice requires activation of the type I interferon (IFN)
response pathway. IFNα and IFNβ therapies have proven promising in humans, but suffer …
response pathway. IFNα and IFNβ therapies have proven promising in humans, but suffer …
Extracellular vesicle–based drug delivery in cancer immunotherapy
S Najafi, J Majidpoor, K Mortezaee - Drug Delivery and Translational …, 2023 - Springer
Extracellular vesicles (EVs) are a group of nanoscale membrane-bound organelles
including exosomes, microvesicles (MVs), membrane particles, and apoptotic bodies, which …
including exosomes, microvesicles (MVs), membrane particles, and apoptotic bodies, which …
Nadofaragene firadenovec: First approval
A Lee - Drugs, 2023 - Springer
Nadofaragene firadenovec (nadofaragene firadenovec-vncg; Adstiladrin®) is a non-
replicating adenoviral vector-based gene therapy developed by Ferring Pharmaceuticals for …
replicating adenoviral vector-based gene therapy developed by Ferring Pharmaceuticals for …